🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oregon governor to sign bill recriminalizing drug use

Published 03/08/2024, 07:23 PM
Updated 03/08/2024, 08:06 PM
© Reuters. FILE PHOTO: Portland police officer David Baer holds up a blue oxycodone pill and a small bag of fentanyl that he just confiscated from a woman getting ready to smoke them in her car in downtown Portland, Oregon, U.S. February 7, 2024. These blue pills ar
EMR
-

By Daniel Trotta

(Reuters) - Oregon Governor Tina Kotek on Friday vowed to sign into law a bill that recriminalizes drug use, more than three years after voters approved the most liberal drug law in the country, one that decriminalized the possession of small amounts of drugs.

"I intend to sign House Bill 4002 and the related prevention and treatment investments within the next 30 days," Kotek, a Democrat, said in a statement.

The reversal, which can impose a misdemeanor sentence of 180 days for drug possession, was an acknowledgment that Measure 110, approved by voters in November 2020, failed in its approach to treat addiction as a public health matter, not a crime.

Even as the state poured money from cannabis taxes into recovery services, cities like Portland experienced people openly consuming drugs in front of stores, trendy restaurants and hotels, many of them crouched over torch lighters held up to sheets of tinfoil or meth pipes.

Meanwhile Oregon's drug overdose deaths, which increased by a third from 2019 to 2020, rose another 44% in 2021, according to state figures.

Under Measure 110, instead of arresting drug users, police could issue $100 citations along with drug treatment information. But there were no ramifications for declining treatment, and state data showed only 4% of those who received citations called the hotline.

In November 2020, Measure 110 won support from 58% of voters. But by August last year, a survey by Emerson (NYSE:EMR) College found 56% of Oregonians supported a total repeal and 64% supported changes.

© Reuters. FILE PHOTO: Portland police officer David Baer holds up a blue oxycodone pill and a small bag of fentanyl that he just confiscated from a woman getting ready to smoke them in her car in downtown Portland, Oregon, U.S. February 7, 2024. These blue pills are often counterfeit, and frequently tainted with fentanyl. REUTERS/Deborah Bloom/File Photo

While HB 4002 reimposes penalties, it also enables local governments and law-enforcement agencies to choose whether they want to offer users the opportunity to pursue drug treatment before going to jail.

Nearly two dozen of Oregon's 36 counties have agreed to opt into the treatment-first approach, the Oregonian reported, citing state lawmakers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.